Financial Reports Latest Updates Industry Maps Economic Calendar

EPS Bio (4183) Annual Reports

Q: Where can I download EPS Bio (4183) annual reports?

Every financial year on this page links straight to the PDF filed with the Market Observation Post System (MOPS), Taiwan's statutory disclosure platform.

Q: What is an investor conference?

The Taiwanese equivalent of an earnings call. Listed companies present quarterly results and file the presentation deck with MOPS, usually in both languages.

Listed on the Taipei Exchange (TPEx), classified under Healthcare. This page collects the company's annual reports, with files served directly by the Market Observation Post System (MOPS).

english presentations

2025

latest year

Company profile

Sector： All Healthcare stocks →
Listing date： 2017-03-09
Incorporated： 2002-10-22
Paid-in capital： NT$238m

Website：Official site ↗

Financial history

Revenue & profit

Quarterly · In mn (TWD)

Revenue 106 mn Net income -1.46 mn

Taiwan filings are cumulative; figures here are restated to single quarters.

Show table：Income statement

Item	2013Q2	2013Q4	2014Q2	2014Q4	2015Q2	2015Q4	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Revenue	—	—	—	—	—	—	—	100	146	99.3	108	80.9	132	69.4	122	108	115	99.9	120	102	137	107	143	110	118	88.5	119	126	147	113	100	146	104	90.9	112	116	151	97.9	134	103	117	120	130	131	119	63.4	106
Gross profit	—	—	—	—	—	—	—	31.7	47.1	22.8	18.4	22.9	37.5	3.39	28.1	24.9	39.3	25.3	25.4	34.4	30.3	29.4	42.2	38.9	24.3	19.6	30.9	29.3	40.8	23.3	25.8	36.9	21.4	22.7	24.3	30.2	38.5	27.3	29.8	34.4	4.81	20.4	27.3	23.1	16.3	9.68	19.7
Operating income	—	—	—	—	—	—	—	7.89	13.2	0.46	-4.42	1.76	19.6	-19.4	7.41	3.54	18.2	4.43	3.99	10.4	8.92	5.12	19.3	15.2	4.54	-3.40	10.6	6.06	19.8	-1.84	5.28	12.9	-0.29	2.89	0.93	9.06	12.0	5.48	5.18	11.0	-16.2	-4.67	2.18	1.02	-7.63	-15.3	-0.57
Pre-tax income	—	—	—	—	—	—	—	2.74	17.8	-8.18	-3.40	0.9	16.0	-24.2	17.6	4.45	20.0	5.13	6.14	8.89	3.85	5.41	17.8	14.6	2.26	-5.58	7.08	4.79	17.2	3.19	6.32	19.0	-1.09	3.12	5.21	13.0	5.16	12.8	8.13	8.09	-11.2	-0.22	-16.4	8.38	-1.39	-13.0	-1.67
Net income	—	—	—	—	—	—	—	2.28	14.7	-7.74	-5.48	0.91	15.0	-22.2	15.4	4.89	17.7	3.51	4.99	6.35	3.59	4.29	14.0	11.7	1.77	-5.35	6.46	3.79	13.7	2.51	4.95	15.3	2.66	2.41	4.18	10.3	4.08	11.8	7.98	6.44	-8.91	1.18	-13.0	6.45	-2.54	-12.3	-1.46

Balance sheet

Quarterly · In mn (TWD)

Total assets 503 mn Total liabilities 236 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Show table：Balance sheet

Item	2013Q2	2013Q4	2014Q2	2014Q4	2015Q2	2015Q4	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Current assets	247	292	227	211	259	246	287	271	303	352	346	331	309	307	327	315	336	355	352	322	333	356	383	365	355	365	383	369	393	405	398	361	348	344	375	384	366	350	397	389	368	373	365	347	355	318	327
Total assets	376	412	343	323	362	339	376	358	389	440	435	419	398	395	413	401	423	555	554	526	535	555	579	559	547	553	571	558	577	585	581	542	528	520	549	561	543	530	576	565	542	550	544	524	533	495	503
Current liabilities	118	152	107	97.8	124	81.9	118	99.1	115	119	138	122	86.7	106	115	100	105	123	135	103	109	126	154	124	111	124	166	150	157	163	172	118	103	95.0	144	147	125	101	160	142	130	142	167	143	155	131	142
Total liabilities	161	192	149	138	161	117	150	130	146	148	167	151	115	133	143	127	130	259	269	236	241	257	283	252	238	249	290	272	278	283	291	236	219	210	257	259	237	212	269	252	237	244	267	241	252	226	236
Equity	215	220	194	186	201	222	226	228	243	292	268	269	284	261	270	275	292	296	284	290	294	298	296	307	309	304	282	286	299	302	290	305	308	311	292	302	306	318	307	313	305	306	277	283	281	269	267

Cash flow

Quarterly · In mn (TWD)

Operating 41.1 mn Investing -2.77 mn Financing -1.43 mn

Positive = cash in, negative = cash out.

Show table：Cash flow statement

Item	2013Q2	2013Q4	2014Q2	2014Q4	2015Q2	2015Q4	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Operating	—	—	—	—	—	—	—	6.68	6.06	15.0	6.04	-12.6	33.9	-12.1	2.74	-15.8	38.2	12.3	-21.9	-8.78	40.2	45.1	14.2	24.3	-3.68	11.8	-24.5	6.22	38.6	33.2	-43.4	-14.1	29.3	14.3	4.05	15.3	21.6	4.25	-13.4	-2.52	-20.7	6.59	3.22	6.84	-16.1	-22.1	41.1
Investing	—	—	—	—	—	—	—	-2.93	-2.42	-4.58	-5.40	-1.25	-1.97	-5.51	-1.93	-2.80	-5.99	-3.53	-2.57	-7.38	-3.67	-1.07	-1.98	-31.8	27.9	-2.53	-3.62	-3.30	-2.68	-2.79	-4.62	-0.44	-7.07	-0.49	-1.02	-6.84	-1.12	-7.84	-2.82	-2.03	-1.70	-9.36	-0.97	-2.28	-11.4	-4.38	-2.77
Financing	—	—	—	—	—	—	—	-9.71	-1.39	55.6	-4.41	-19.6	-0.57	-0.57	-0.58	-7.72	-0.58	-1.28	-1.29	-18.0	-1.30	-1.33	-1.34	-18.0	-1.35	-1.36	-1.36	-29.9	-1.37	-1.38	-1.38	-18.4	-1.39	-1.39	-1.39	-24.7	-1.41	-1.41	-1.42	-20.5	-1.43	-1.40	-1.84	-17.4	38.6	-1.42	-1.43
Cash at period end	111	112	71.1	100	133	127	149	140	145	209	205	173	201	179	185	160	195	203	178	144	176	219	229	202	222	225	194	166	203	235	187	156	179	191	194	179	195	194	178	151	129	126	120	110	123	95.4	132

Profitability

Quarterly · %

Gross margin 18.6% Operating margin -0.5% Net margin -1.4%

Gross, operating and net margin = the respective profit ÷ revenue.

Show table：Profitability

Item	2013Q2	2013Q4	2014Q2	2014Q4	2015Q2	2015Q4	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Gross margin	—	—	—	—	—	—	—	31.6%	32.3%	22.9%	17.1%	28.3%	28.4%	4.9%	23.0%	23.1%	34.3%	25.3%	21.1%	33.6%	22.1%	27.5%	29.5%	35.5%	20.6%	22.1%	25.9%	23.4%	27.8%	20.7%	25.6%	25.2%	20.6%	24.9%	21.7%	25.9%	25.6%	27.9%	22.3%	33.5%	4.1%	17.0%	20.9%	17.7%	13.7%	15.3%	18.6%
Operating margin	—	—	—	—	—	—	—	7.9%	9.1%	0.5%	-4.1%	2.2%	14.8%	-27.9%	6.1%	3.3%	15.9%	4.4%	3.3%	10.2%	6.5%	4.8%	13.5%	13.9%	3.9%	-3.8%	8.9%	4.8%	13.5%	-1.6%	5.3%	8.8%	-0.3%	3.2%	0.8%	7.8%	8.0%	5.6%	3.9%	10.7%	-13.9%	-3.9%	1.7%	0.8%	-6.4%	-24.1%	-0.5%
Net margin	—	—	—	—	—	—	—	2.3%	10.1%	-7.8%	-5.1%	1.1%	11.4%	-31.9%	12.6%	4.5%	15.4%	3.5%	4.2%	6.2%	2.6%	4.0%	9.8%	10.7%	1.5%	-6.0%	5.4%	3.0%	9.3%	2.2%	4.9%	10.4%	2.5%	2.7%	3.7%	8.9%	2.7%	12.0%	6.0%	6.3%	-7.6%	1.0%	-9.9%	4.9%	-2.1%	-19.4%	-1.4%

Returns & leverage

Quarterly · %

ROE -3.6% ROA -1.9% Debt ratio 46.9%

ROE / ROA = trailing four-quarter net income ÷ average equity / total assets (annual mode: the year’s net income ÷ average of opening and closing). Not computed when the denominator is zero or negative.

Show table：Returns & leverage

Item	2013Q2	2013Q4	2014Q2	2014Q4	2015Q2	2015Q4	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
ROE	—	—	—	—	—	—	—	—	—	—	1.5%	1.0%	1.0%	-4.2%	3.4%	4.8%	5.5%	14.9%	11.2%	11.5%	6.3%	6.5%	9.7%	11.2%	10.5%	7.3%	5.0%	2.3%	6.1%	8.8%	8.7%	12.3%	8.3%	8.3%	8.4%	6.4%	6.8%	9.7%	11.4%	9.8%	5.7%	2.1%	-4.9%	-4.8%	-2.7%	-7.4%	-3.6%
ROA	—	—	—	—	—	—	—	—	—	—	0.9%	0.6%	0.7%	-2.8%	2.2%	3.2%	3.9%	8.7%	6.4%	7.0%	3.9%	3.5%	5.0%	6.2%	5.9%	4.0%	2.5%	1.2%	3.3%	4.7%	4.3%	6.6%	4.6%	4.6%	4.3%	3.5%	3.9%	5.8%	6.1%	5.4%	3.2%	1.2%	-2.5%	-2.6%	-1.5%	-4.1%	-1.9%
Debt ratio	42.8%	46.5%	43.4%	42.6%	44.4%	34.4%	39.8%	36.3%	37.5%	33.6%	38.4%	35.9%	28.8%	33.8%	34.6%	31.6%	30.8%	46.7%	48.7%	44.8%	45.0%	46.3%	48.9%	45.1%	43.5%	45.1%	50.7%	48.8%	48.2%	48.4%	50.1%	43.6%	41.6%	40.3%	46.9%	46.2%	43.7%	40.0%	46.8%	44.6%	43.8%	44.4%	49.1%	46.0%	47.3%	45.7%	46.9%

EPS

Quarterly · NT$

EPS NT$-0.06

Show table：EPS

Item	2013Q2	2013Q4	2014Q2	2014Q4	2015Q2	2015Q4	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
EPS（NT$）	—	—	—	—	—	—	—	0.11	0.71	-0.36	-0.22	0.05	0.65	-0.93	0.65	0.20	0.74	0.15	0.21	0.26	0.15	0.18	0.59	0.49	0.07	-0.22	0.27	0.16	0.57	0.11	0.20	0.64	0.12	0.10	0.18	0.43	0.17	0.50	0.33	0.27	-0.37	0.05	-0.54	0.27	-0.11	-0.52	-0.06

Revenue & profit

Year-to-date · In mn (TWD)

Revenue 169 mn Net income -13.8 mn

Year-to-date = summed from the first quarter of the fiscal year; balance-sheet items are period-end balances.

Balance sheet

Year-to-date · In mn (TWD)

Total assets 503 mn Total liabilities 236 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Cash flow

Year-to-date · In mn (TWD)

Operating 18.9 mn Investing -7.15 mn Financing -2.85 mn

Positive = cash in, negative = cash out.

Profitability

Year-to-date · %

Gross margin 17.4% Operating margin -9.4% Net margin -8.1%

Gross, operating and net margin = the respective profit ÷ revenue.

Returns & leverage

Year-to-date · %

ROE -3.6% ROA -1.9% Debt ratio 46.9%

EPS

Year-to-date · NT$

EPS NT$-0.58

Revenue & profit

Annual · In mn (TWD)

Revenue 500 mn Net income -7.87 mn

Annual = sum of four quarters of a complete fiscal year (incomplete years are omitted); balance-sheet items are year-end balances.

Show table：Income statement

Item	2017	2018	2019	2020	2021	2022	2023	2024	2025
Revenue	420	414	459	478	480	463	470	451	500
Gross profit	102	95.7	115	135	121	107	116	96.3	87.0
Operating income	17.4	9.84	27.7	44.2	33.1	16.0	24.9	5.40	-9.10
Pre-tax income	5.31	17.8	24.0	40.1	23.5	27.5	26.5	17.8	-9.67
Net income	2.72	15.8	18.4	31.7	18.6	25.4	21.0	17.3	-7.87

Balance sheet

Annual · In mn (TWD)

Total assets 533 mn Total liabilities 252 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Show table：Balance sheet

Item	2017	2018	2019	2020	2021	2022	2023	2024	2025
Current assets	309	336	333	355	393	348	366	368	355
Total assets	398	423	535	547	577	528	543	542	533
Current liabilities	86.7	105	109	111	157	103	125	130	155
Total liabilities	115	130	241	238	278	219	237	237	252
Equity	284	292	294	309	299	308	306	305	281

Cash flow

Annual · In mn (TWD)

Operating 0.6 mn Investing -24.0 mn Financing 18.0 mn

Positive = cash in, negative = cash out.

Show table：Cash flow statement

Item	2017	2018	2019	2020	2021	2022	2023	2024	2025
Operating	42.4	13.0	21.9	79.9	32.1	5.00	55.2	-32.3	0.6
Investing	-13.2	-16.2	-17.1	-6.98	-12.1	-14.9	-9.48	-14.4	-24.0
Financing	31.0	-9.45	-21.8	-22.0	-34.0	-22.6	-28.9	-24.7	18.0
Cash at period end	201	195	176	222	203	179	195	129	123

Profitability

Annual · %

Gross margin 17.4% Operating margin -1.8% Net margin -1.6%

Gross, operating and net margin = the respective profit ÷ revenue.

Show table：Profitability

Item	2017	2018	2019	2020	2021	2022	2023	2024	2025
Gross margin	24.2%	23.1%	25.1%	28.2%	25.1%	23.2%	24.6%	21.3%	17.4%
Operating margin	4.1%	2.4%	6.0%	9.3%	6.9%	3.5%	5.3%	1.2%	-1.8%
Net margin	0.7%	3.8%	4.0%	6.6%	3.9%	5.5%	4.5%	3.8%	-1.6%

Returns & leverage

Annual · %

ROE -2.7% ROA -1.5% Debt ratio 47.3%

Show table：Returns & leverage

Item	2017	2018	2019	2020	2021	2022	2023	2024	2025
ROE	1.0%	5.5%	6.3%	10.5%	6.1%	8.3%	6.8%	5.7%	-2.7%
ROA	0.7%	3.9%	3.9%	5.9%	3.3%	4.6%	3.9%	3.2%	-1.5%
Debt ratio	28.8%	30.8%	45.0%	43.5%	48.2%	41.6%	43.7%	43.8%	47.3%

EPS

Annual · NT$

EPS NT$-0.33

Show table：EPS

Item	2017	2018	2019	2020	2021	2022	2023	2024	2025
EPS（NT$）	0.12	0.66	0.77	1.33	0.78	1.07	0.88	0.73	-0.33

Source: Taiwan MOPS financial statements

EPS Bio annual reports

	English	Chinese
2025 (ROC 114)	Chinese only	PDF
2024 (ROC 113)	Chinese only	PDF

2 of the 2 financial years listed above have no English edition. Taiwanese issuers below a certain size are not required to file one; the Chinese PDF is linked instead so the year is not simply missing.

About EPS Bio filings

Where can I download EPS Bio (4183) annual reports?

Every financial year in the table above links straight to the PDF filed with the Market Observation Post System (MOPS), Taiwan's statutory disclosure platform.

Why are some years Chinese only?

Filing an English annual report is only mandatory for larger Taiwanese issuers; smaller companies and those on the Emerging Stock Board file in Chinese. Where no English edition exists this site links the Chinese PDF rather than leaving the year blank, so you can still reach the document.

What is an investor conference (法人說明會)?

It is the Taiwanese equivalent of an earnings call or analyst briefing. Listed companies present quarterly results and outlook, and file the presentation deck with MOPS — usually in both Chinese and English. Many also publish a webcast recording.

How does Taiwan's reporting calendar work?

Taiwanese issuers file quarterly financial reports plus an annual report, and publish monthly revenue figures — a disclosure cadence that is more frequent than Hong Kong or Singapore. Financial years are numbered using the ROC calendar (ROC 114 = 2025); this site shows both.

Source: Market Observation Post System (MOPS), Taiwan. All PDF links point to the original files; nothing is re-hosted here.
Browse all Taiwan listed companies, or read this page in Chinese — the Chinese edition also carries the letter to shareholders and the revenue breakdown.